Scientific ReportsBiophysicsPeer-reviewed journal article
Drug resistant pancreatic cancer cells exhibit altered biophysical interactions with stromal fibroblasts in imaging studies of 3D co-culture models
Eric Struth, Maryam LabafiD, Vida KarimniaiD, Yiran LiuiD, Gwendolyn M. CrameriD, Joanna B. DahliD, Frank John SlackiD, Kourosh ZarringhalamiD, Jonathan P. CelliiD
Abstract
Interactions between tumor and stromal cells are well known to play a prominent roles in progression of pancreatic ductal adenocarcinoma (PDAC). As knowledge of stromal crosstalk in PDAC has evolved, it has become clear that cancer associated fibroblasts can play both tumor promoting and tumor suppressive roles through a combination of paracrine crosstalk and juxtacrine interactions involving direct physical contact. Another major contributor to dismal survival statistics for PDAC is development of resistance to chemotherapy drugs. Though less is known about how the acquisition of chemoresistance impacts upon tumor-stromal crosstalk. Here, we use 3D co-culture geometries to recapitulate juxtacrine interactions between epithelial and stromal cells. In particular, extracellular matrix (ECM) overlay cultures in which stromal cells (pancreatic stellate cells, or normal human fibroblasts) are placed adjacent to PDAC cells (PANC1), result in direct heterotypic cell adhesions accompanied by dramatic fibroblast contractility which leads to highly condensed macroscopic multicellular aggregates as detected using particle image velocimetry (PIV) analysis to quantify cell velocities over the course of time lapse movie sequences. To investigate how drug resistance impacts these juxtacrine interactions we contrast cultures in which PANC1 are substituted with a drug resistant subline (PANC1-OR) previously established in our lab. We find that heterotypic cell-cell interactions are highly suppressed in drug-resistant cells relative to the parental PANC1 cells. To investigate further we conduct RNA-seq and bioinformatics analysis to identify differential gene expression in PANC1 and PANC1-OR, which shows that negative regulation of cell adhesion molecules, consistent with increased epithelial mesenchymal transition (EMT), is also consistent with loss of hetrotypic cell-cell contact necessary for the contractile behavior observed in drug naive cultures. Overall these findings elucidate the role of drug-resistance in inhibiting an avenue of stromal crosstalk which is associated with tumor suppression and also help to establish cell culture conditions useful for further mechanistic investigation.
- Citations
- 12
- FWCI
- 2.12
- Field percentile
- top 10%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Engineered extracellular matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids
B. L. LeSavage, A. E. Gilchrist, … S. C. Heilshorn·bioRxiv·Apr 22, 2022
- Tumor Cell Death Drives Tumor-Promoting IL-6+ iCAF formation via P2X7-activation
Ciarán McDonnell, Valeriya V. Zinina, … Mark R. Schmitt·bioRxiv·Mar 20, 2026
- Tumor nutrient stress gives rise to a drug tolerant cell state in pancreatic cancer
Colin S. Sheehan, Lyndon Hu, … Alexander Muir·bioRxiv·Sep 4, 2025
- Differential modulation of cellular phenotype and drug sensitivity by extracellular matrix proteins in primary and metastatic pancreatic cancer cells
O. H. Usman, S. Kumar, … J. Irianto·Molecular Biology of the CellPeer-reviewed·Dec 1, 2023
- IL-1-activated cancer-associated fibroblasts promote STAT1-driven transcriptional reprogramming of pancreatic tumour cells
Catarina Pelicano, Igor V. Chernukhin, … Shalini V. Rao·bioRxiv·May 29, 2026
- Altered Mechanobiology of PDAC Cells with Acquired Chemoresistance to Gemcitabine and Paclitaxel.
A. Gregori, C. Bergonzini, … T. Schmidt·bioRxiv·Apr 10, 2024